Conversely, a higher frequency of PIK3CA mutations occurred in previously reported HPV‐positive cervical adeno‐ and squamous cell carcinomas, head and neck cancers [36, 37], and the UCSCC analyzed here (17–34%) as compared to previously described SCLCs (3–5%; Fig. 4A). This evidence concerns the gene PIK3CA and head and neck cancer.